DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Hung IF, Lung KC, Tso EY. et al.
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.
Lancet (London, England) 2020;
DOI: 10.1016/s0140-6736(20)31042-4.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.